Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality
- PMID: 30659754
- PMCID: PMC6591021
- DOI: 10.1111/ajt.15265
Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality
Abstract
The prelisting variables essential for creating an accurate heart transplant allocation score based on survival are unknown. To identify these we studied mortality of adults on the active heart transplant waiting list in the Scientific Registry of Transplant Recipients database from January 1, 2004 to August 31, 2015. There were 33 069 candidates awaiting heart transplantation: 7681 UNOS Status 1A, 13 027 Status 1B, and 12 361 Status 2. During a median waitlist follow-up of 4.3 months, 5514 candidates died. Variables of importance for waitlist mortality were identified by machine learning using Random Survival Forests. Strong correlates predicting survival were estimated glomerular filtration rate (eGFR), serum albumin, extracorporeal membrane oxygenation, ventricular assist device, mechanical ventilation, peak oxygen capacity, hemodynamics, inotrope support, and type of heart disease with less predictive variables including antiarrhythmic agents, history of stroke, vascular disease, prior malignancy, and prior tobacco use. Complex interactions were identified such as an additive risk in mortality based on renal function and serum albumin, and sex-differences in mortality when eGFR >40 mL/min/1.73 m. Most predictive variables for waitlist mortality are in the current tiered allocation system except for eGFR and serum albumin which have an additive risk and complex interactions.
Keywords: Scientific Registry for Transplant Recipients (SRTR); artificial organs/support devices: heart/ventricular assist devices; clinical research/practice; gender; health services and outcomes research; heart transplantation/cardiology; organ procurement and allocation; organ transplantation in general; patient survival; waitlist management.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.
Conflict of interest statement
DISCLOSURE
The authors have no conflicts of interest to disclose as described by the
Figures
Similar articles
-
Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation.Circ Heart Fail. 2017 Jun;10(6):e003635. doi: 10.1161/CIRCHEARTFAILURE.116.003635. Circ Heart Fail. 2017. PMID: 28611123 Free PMC article.
-
Heart Transplantation: An In-Depth Survival Analysis.JACC Heart Fail. 2020 Jul;8(7):557-568. doi: 10.1016/j.jchf.2020.03.014. Epub 2020 Jun 10. JACC Heart Fail. 2020. PMID: 32535125 Free PMC article.
-
Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm.JACC Heart Fail. 2014 Apr;2(2):166-77. doi: 10.1016/j.jchf.2013.11.005. JACC Heart Fail. 2014. PMID: 24720925 Free PMC article.
-
Matching the Market for Heart Transplantation.Circ Heart Fail. 2016 Apr;9(4):e002679. doi: 10.1161/CIRCHEARTFAILURE.115.002679. Circ Heart Fail. 2016. PMID: 27072859 Free PMC article. Review.
-
A national assessment of one-year heart outcomes after the 2018 adult heart allocation change.J Heart Lung Transplant. 2023 Feb;42(2):196-205. doi: 10.1016/j.healun.2022.08.018. Epub 2022 Aug 28. J Heart Lung Transplant. 2023. PMID: 36184382 Review.
Cited by
-
Machine learning and artificial intelligence in cardiac transplantation: A systematic review.Artif Organs. 2022 Sep;46(9):1741-1753. doi: 10.1111/aor.14334. Epub 2022 Jun 20. Artif Organs. 2022. PMID: 35719121 Free PMC article. Review.
-
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers.bioRxiv [Preprint]. 2023 Dec 29:2023.07.10.548412. doi: 10.1101/2023.07.10.548412. bioRxiv. 2023. Update in: Elife. 2024 Jun 03;12:RP89017. doi: 10.7554/eLife.89017 PMID: 37502871 Free PMC article. Updated. Preprint.
-
Impact of Muscle Mass as a Prognostic Factor for Failed Waiting Time Prior to Heart Transplantation.Front Cardiovasc Med. 2021 Oct 18;8:731293. doi: 10.3389/fcvm.2021.731293. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34733892 Free PMC article.
-
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis.J Neurooncol. 2024 Aug;169(1):105-117. doi: 10.1007/s11060-024-04706-2. Epub 2024 Jun 5. J Neurooncol. 2024. PMID: 38837019
-
Association of high-priority exceptions with waitlist mortality among heart transplant candidates.J Heart Lung Transplant. 2023 Sep;42(9):1175-1182. doi: 10.1016/j.healun.2023.05.009. Epub 2023 May 22. J Heart Lung Transplant. 2023. PMID: 37225029 Free PMC article.
References
-
- Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med January 6 2011;364(1):11–21. - PubMed
-
- Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the Management of Heart FailureA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2013. - PubMed
-
- Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation March 21 2006;113(11):1424–1433. - PubMed
-
- Jasseron C, Legeai C, Jacquelinet C, et al. Prediction of Waitlist Mortality in Adult Heart Transplant Candidates: The Candidate Risk Score. Transplantation September 2017;101(9):2175–2182. - PubMed
-
- Organ Procurement and Transplantation Network: Policies Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_... Last accessed on January 29, 2017.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
